Advisornet Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $754 | Buy |
6
+2
| +50% | +$251 | ﹤0.01% | 1961 |
|
|
2025
Q1 | $442 | Hold |
4
| – | – | ﹤0.01% | 1958 |
|
|
2024
Q4 | $546 | Sell |
4
-18
| -82% | -$2.46K | ﹤0.01% | 1745 |
|
|
2024
Q3 | $2.54K | Hold |
22
| – | – | ﹤0.01% | 1697 |
|
|
2024
Q2 | $3.03K | Hold |
22
| – | – | ﹤0.01% | 1540 |
|
|
2024
Q1 | $3.03K | Sell |
22
-6
| -21% | -$827 | ﹤0.01% | 1530 |
|
|
2023
Q4 | $3.69K | Buy |
28
+24
| +600% | +$3.16K | ﹤0.01% | 1555 |
|
|
2023
Q3 | $450 | Hold |
4
| – | – | ﹤0.01% | 2009 |
|
|
2023
Q2 | $377 | Buy |
4
+1
| +33% | +$94 | ﹤0.01% | 2108 |
|
|
2023
Q1 | $304 | Buy |
3
+1
| +50% | +$101 | ﹤0.01% | 2182 |
|
|
2022
Q4 | $239 | Buy |
+2
| New | +$239 | ﹤0.01% | 2183 |
|